BRAINIAC AI Project to Halve Dementia Diagnosis Times via NHS Clinics

Exeter-led £20m project targets earlier dementia diagnosis

The University of Exeter is spearheading a new £20m project designed to transform how the NHS detects and manages dementia. Known as BRAINIAC—short for AI and Emerging Technologies for Next Generation Brain Health Clinics—the initiative links 11 universities and 10 NHS sites over the next six years. The project, as reported by the BBC, seeks to establish a major research platform to identify the most effective methods for diagnosing, preventing, and treating the condition.

The scale of the challenge is significant. Currently, about 982,000 people in the UK live with dementia. Projections suggest that number will climb to 1.4 million by 2040, with the annual economic cost expected to more than double to £90bn.

Reducing wait times and identifying risk

The project aims to address these rising costs by fundamentally changing the diagnostic pathway. UK Research and Innovation (UKRI) has committed up to £80m to support researchers in developing new tools. The goal is to enable the diagnosis of 92% of people referred with suspected dementia within 18 weeks by 2029.

The clinics intend to make the assessment process 30% to 50% faster than current standards. Furthermore, researchers aim to identify more than 40% of the people assessed as being at early risk before clinical symptoms even develop.

Clinical integration and personalized prevention

David Llewellyn, professor of clinical epidemiology and digital health at the University of Exeter’s medical school and director of BRAINIAC, identified detection as the “hardest problem” in the field.

The tools we build in these NHS clinics will let us pick up the first signs before symptoms show, and offer people a personalised prevention plan to help them keep their brains sharp for longer.

The focus is not solely on digital innovation but on ensuring these tools function within the constraints of real-world medical settings. Chris Fox, professor of clinical psychiatry and deputy director of the project, emphasized that current treatments are often only effective if intervention occurs early.

BRAINIAC will give the NHS the tools to do that at scale, designed with patients and clinicians from the start so they work in a busy clinic and not just on paper.

The economic and human stakes

The shift toward early detection represents a strategic pivot in how the healthcare system manages neurodegenerative conditions. While the economic burden of dementia is projected to reach £90bn annually, the human impact remains the primary driver for these clinics. By integrating AI and emerging technologies directly into the 10 participating NHS clinics, the project hopes to move away from reactive care toward a model of personalized prevention.

Whether these technologies can consistently meet the 18-week diagnostic target at scale—while maintaining the accuracy required for clinical safety—remains the central question for the six-year rollout. As the project begins to integrate these tools into active clinical environments, the results will likely serve as a benchmark for how artificial intelligence can be safely deployed in public health to manage the growing prevalence of age-related cognitive decline.